The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Executive Chairman

11 Apr 2011 07:00

RNS Number : 6273E
Fitbug Holdings PLC
11 April 2011
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

11 April 2011

Fitbug Holdings Plc ('Fitbug' or 'the Company')

Appointment of Executive Chairman

 

Fitbug Holdings Plc, the AIM traded provider of online personal health and well-being services, has appointed Mr. Fergus Kee as Executive Chairman with immediate effect. He replaces Allan Fisher who is to step down from his role as Executive Chairman to pursue other business interests but remains with the Company as a Non-executive Director.

 

Mr. Kee has spent most of his career in the health and retail sectors including 18 years with international healthcare company, Bupa, where he played a leading role in developing and implementing its strategy and seeing its revenues increase from £2.2 billion in 2000 to £6.9 billion and profits rise from £65 million in 2000 to £428 million in 2009. Most recently he was Managing Director of the UK and North American division and CEO of Bupa Insurance Limited but prior to this he was Managing Director of UK Health and Wellbeing and Finance Director of UK Operations. Earlier in his career, having qualified as a Chartered Accountant with KPMG, he held senior finance roles at Proctor & Gamble and at the Burton Group Plc. He was also a member of the Association of British Insurers (ABI) Board and former Chair of the ABI Audit and Health Committees.

 

Following his appointment, Mr Kee has agreed to invest £200,000 in Fitbug by way of a placing of 10,000,000 1 pence ordinary shares at a price of 2 pence per share. This brings his total holding in the company to 20,000,000 ordinary shares representing 18.5% of the issued share capital of the Company. The independent directors of the Company, being David Turner, Allan Fisher, Geoffrey Simmonds, Paul Landau and Andrew Brummer consider, having consulted with Seymour Pierce, that the terms of the investment by Mr Kee is fair and reasonable in so far as the shareholders are concerned. The proceeds of this are to be used to strengthen the Company's working capital.

 

Fitbug Holdings Chief Executive David Turner said, "We couldn't have hoped for a better person to join our team - Fergus' deep knowledge of the health sector and wide experience in developing and managing strategies will be invaluable as we drive Fitbug's international growth plans forward. In particular his insight into North America will be key as we focus our resources on developing Fitbug's presence in this very large, attractive market. The Board welcomes his decision to join the business and invest as a shareholder.

 

"I would also like to thank Allan for the time he has given Fitbug. He has been instrumental in building the business to its current stage, where it is, I believe, now well placed for profitable growth. I look forward to continuing to work with him as the Company evolves and builds its presence in the North American market."

 

Fergus Kee said, "The need for health solutions to help people improve their lifestyle and health is not new. However the market opportunity for Fitbug is now becoming much clearer and more tangible, particularly in the USA. I am increasingly optimistic regarding prospects for this business and believe it can deliver a profitable return to shareholders."

 

Mr. Fergus Alexander Kee, aged 50, is or has been a director of the following companies during the previous five years:

 

Current Directorships:

Directorships held within the previous 10 years:

Bupa US Holdings II, Inc

Bupa Health Assurance Limited

Bupa Insurance Limited

Bupa Insurance Services Limited

Bupa Health Dialog Limited

Bupa Home Healthcare Group Limited

Bupa Home Healthcare Holdings Limited

Bupa Home Healthcare Limited

Clinovia Healthcare Services Limited

Cromwell Health Group Limited

Guardian Homecare Essex Limited

Guardian Homecare Kent Limited

Guardian Homecare Services (Surrey & Mid-Sussex) Limited

Guardian Homecare UK Limited

Health Dialog Espana SL

Health Dialog Services Corporation

Integrity Health Care Services Limited

Medical Services International Limited

Cromwell Medical Services Limited

Bupa Health at Work Limited

Bupa Occupational Health Limited

Bupa Travel Services Limited

Bupa Wellness Group Limited

CHP Limited

Community Hospital Partnership Limited

Independent Healthcare Limited

Mercia Health Benefits Services Limited

Mercia Investment Advisers Limited

Occupational Health Care Limited

Personal Effectiveness Centre Limited

The Coventry & Warwickshire Hospital Saturday Fund

Clinilink Limited

Clinovia Trustees Limited

Patriot Merger Sub Inc

Quinn HC Services Limited (formerly BUPA Ireland Services Limited)

Quinn Healthcare Limited (formerly BUPA Ireland Limited)

Interactive Health and Fitness Limited (in Voluntary Members Liquidation)

Barbican Sportcare Limited

BUPA Medical Centre Croydon Limited

BUPA Mobile Screening Limited

 

There is no other information that is required to be disclosed pursuant to paragraph (g) of Schedule Two to the AIM Rules for Companies.

 

Application has been made to the London Stock Exchange for admission of the 10,000,000 new ordinary shares to be admitted to trading on AIM. Admission is expected to occur on 15 April 2011.

 

For the purposes of the Disclosure and Transparency Rules, Fitbug's total issued share capital following the issue of these shares consists of 107,987,194 ordinary shares of 1 penny each.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Fitbug, under the Disclosure and Transparency Rules.

 

 

** ENDS **

 

For further information visit www.fitbugholdings.com or contact:

Andrew Brummer

Fitbug Holdings Plc

Tel: 020 7449 1000

Mark Percy

Seymour Pierce

Tel: 020 7107 8000

Catherine Leftley

Seymour Pierce

Tel: 020 7107 8000

Jon Levinson

Rivington Street Corporate Finance Limited

Tel: 020 7562 3357

Isabel de Salis

St Brides Media & Finance Ltd

Tel: 020 7236 1177

Elisabeth Cowell

St Brides Media & Finance Ltd

Tel: 020 7236 1177

 

 

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to fitbug.com to provide an understanding of each user's daily activity achievements, with web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement. 

 

 Key market sectors include health insurance and rewards providers, workplace health programmes, Primary Care Trusts, fitness operators and consumers. Increasingly, Fitbug's platform acts as the driving force behind third party services such as white label sites, activity driven games & challenge microsites and rewards programmes.

 The Company's main focus is now on building strategic partnerships with organisations which can integrate Fitbug into their own service/product offerings or resell to their customer base. 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADKFDQABKDDQK
Date   Source Headline
23rd Apr 20247:00 amRNSCancellation - Bidstack Group PLC
22nd Mar 20241:11 pmRNSAppointment of Administrators & Nomad Resignation
11th Mar 20247:30 amRNSSuspension - Bidstack Group PLC
11th Mar 20247:00 amRNSIntention to Appoint Administrators & Suspension
5th Feb 20247:00 amRNSUpdate on CLN, Financial Update & Strategic Review
22nd Dec 20237:00 amRNSSettlement & new commercial partnership - Azerion
1st Nov 20237:00 amRNSChange of Registered Office
18th Oct 20233:45 pmRNSProposed CLN, Share Reorganisation and VST Update
29th Sep 20237:00 amRNSBoard Change
29th Sep 20237:00 amRNSProposed New Commercial Partnership
29th Sep 20237:00 amRNSInterim Results
30th Aug 20237:00 amRNSVenatus Advertising Sales Partnership
23rd Aug 20234:47 pmRNSTR-1: Notification of Major Holdings
21st Jul 202311:23 amRNS2023 Annual General Meeting Results
18th Jul 202311:46 amRNSGeneral Meeting Requisition Request withdrawn
18th Jul 20237:00 amRNSBoard Changes
13th Jul 20231:32 pmRNSVirtual stadium partnership with first NFL team
11th Jul 20237:00 amRNSRequisitioned General Meeting
5th Jul 20237:00 amRNSRequest to requisition a General Meeting
21st Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
20th Jun 20238:18 amRNSFinal Results and Annual Report - replacement
20th Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
1st Mar 20235:28 pmRNSComment on Azerion Statement
15th Feb 20237:00 amRNSBidstack appoints Thomas Bullen as CFO
13th Feb 20232:05 pmRNSSecond Price Monitoring Extn
13th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20237:00 amRNSTrading and Operational Update
18th Jan 202311:22 amRNSChange of Registered Office
3rd Jan 202311:05 amRNSSecond Price Monitoring Extn
3rd Jan 202311:00 amRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSAzerion Update
29th Dec 20227:00 amRNSBoard Changes
9th Dec 202211:04 amRNSGrant of LTIP Options
8th Dec 20227:00 amRNSExercise of Options, Issue of Equity & TVR
6th Dec 202211:03 amRNSTR-1: Notification of major holdings
5th Dec 20227:00 amRNSBidstack adds 2 titles with a AAA game publisher
1st Nov 20223:39 pmRNSTR-1: Notification of major holdings
31st Oct 20223:35 pmRNSTotal Voting Rights
31st Oct 20223:21 pmRNSTR-1: Notification of major holdings
31st Oct 20222:16 pmRNSTR-1: Notification of major holdings
31st Oct 202211:54 amRNSTR-1: Notification of major holdings
28th Oct 20224:16 pmRNSTR-1: Notification of Major Holdings
28th Oct 20227:00 amRNSUpdate re Press Commentary
26th Oct 20223:45 pmRNSAdmission of Ordinary Shares and TVR
26th Oct 20227:00 amRNSStrategy Update
25th Oct 202212:08 pmRNSResults of General Meeting
13th Oct 20227:00 amRNSBidstack appoints Camila Franklin as COO
6th Oct 20226:28 pmRNSResults of REX Retail Offer
6th Oct 20228:06 amRNSResults of Placing and Subscription
5th Oct 20224:36 pmRNSREX Retail Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.